No Association of 25-Hydroxyvitamin D With Exacerbations in Primary Care Patients With COPD
about
Influence of diet and obesity on COPD development and outcomesThe causes and consequences of seasonal variation in COPD exacerbations.Emphasizing the health benefits of vitamin D for those with neurodevelopmental disorders and intellectual disabilitiesSevere vitamin D deficiency is associated with frequent exacerbations and hospitalization in COPD patients.COPD: balancing oxidants and antioxidants.Vitamin D, vitamin D binding protein, and longitudinal outcomes in COPDPrediction of COPD-specific health-related quality of life in primary care COPD patients: a prospective cohort study.Muscular and functional effects of partitioning exercising muscle mass in patients with chronic obstructive pulmonary disease - a study protocol for a randomized controlled trialVitamin D Deficiency and Insufficiency in Hospitalized COPD PatientsParathyroid Hormone as a Novel Biomarker for Chronic Obstructive Pulmonary Disease: Korean National Health and Nutrition Examination Survey.Lung function, 25-hydroxyvitamin D concentrations and mortality in US adultsVitamin D deficiency exacerbates COPD-like characteristics in the lungs of cigarette smoke-exposed miceThe association between vitamin D and COPD risk, severity, and exacerbation: an updated systematic review and meta-analysis.Serum 25-Hydroxyvitamin D Levels are not Associated with Adverse Outcomes in Clostridium Difficile Infection.Musculoskeletal disorders in chronic obstructive pulmonary disease.Relationship of vitamin D status with lung function and exercise capacity in COPD.Assessment of osteoporosis using the FRAX method and the importance of vitamin D levels in COPD patients.Vitamin D deficiency: What does it mean for chronic obstructive pulmonary disease (COPD)? a compherensive review for pulmonologists.A time for everything and everything in its time - exploring the mechanisms underlying seasonality of COPD exacerbations
P2860
Q27026426-4EA6D2A9-B476-4038-B004-EA42ACBDB6DEQ34353043-B61C9A51-12C3-4C3D-9AFB-EEB7A6D88CA0Q34465429-52CC05AB-79A3-473E-B531-AFB0295954F2Q34728548-47431B17-B09A-4CA9-BF7B-557141F4FE86Q35063488-59AC6B7E-39A4-41E2-9F2A-777855DE6573Q35213372-80D06469-69C0-4B1E-BB74-1C3217B85A76Q35216272-3C1199E2-34F1-44EE-ADE0-0994E2E8188DQ35580654-5BE12385-9E22-4250-9F4F-F6386D64E664Q35654570-90E6CD73-C447-4694-972E-5A94196C92B0Q35785008-A71CAC4E-A515-436C-92EA-F4BC65770EAEQ36061376-8C64EB45-F494-49D3-A39B-30CB7C03A5C4Q36071318-FAE37F76-02F9-4D43-85D1-C8EBC4F33678Q37365510-63A9CA35-557D-4AE4-BEDF-1842AB14DE16Q40133989-D00896A0-0823-410C-B68C-B2E994CD7F69Q42181451-D9AACF8F-F3B0-4DC1-9F1E-5A6B751E6714Q48041050-A821E463-50BA-4F9D-868B-9D14BA9AF368Q49166134-1CF5746D-55B4-4847-AAA1-B2E721AD4A7FQ54474414-F7D51F97-7B25-492A-B9DC-2EE6DFD944EBQ57103023-2899B6B0-933E-4837-9FEA-9562F1656D77
P2860
No Association of 25-Hydroxyvitamin D With Exacerbations in Primary Care Patients With COPD
description
im Januar 2014 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2014
@uk
name
No Association of 25-Hydroxyvi ...... rimary Care Patients With COPD
@en
No Association of 25-Hydroxyvi ...... rimary Care Patients With COPD
@nl
type
label
No Association of 25-Hydroxyvi ...... rimary Care Patients With COPD
@en
No Association of 25-Hydroxyvi ...... rimary Care Patients With COPD
@nl
prefLabel
No Association of 25-Hydroxyvi ...... rimary Care Patients With COPD
@en
No Association of 25-Hydroxyvi ...... rimary Care Patients With COPD
@nl
P2093
P356
P1433
P1476
No Association of 25-Hydroxyvi ...... rimary Care Patients With COPD
@en
P2093
Heike Bischoff-Ferrari
Lara Siebeling
Marco Zoller
Milo A. Puhan
P356
10.1378/CHEST.13-1296
P407
P577
2014-01-01T00:00:00Z